Cutera, Inc. (NASDAQ:CUTR) EVP Larry Laber sold 11,345 shares of the stock in a transaction on Friday, June 15th. The shares were sold at an average price of $43.43, for a total transaction of $492,713.35. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Cutera traded down $1.35, reaching $43.05, during trading hours on Tuesday, MarketBeat reports. The stock had a trading volume of 198,100 shares, compared to its average volume of 223,682. The firm has a market cap of $591.74 million, a PE ratio of 57.01, a price-to-earnings-growth ratio of 3.81 and a beta of 0.48. Cutera, Inc. has a 52 week low of $23.85 and a 52 week high of $56.05.
Cutera (NASDAQ:CUTR) last announced its quarterly earnings results on Tuesday, May 8th. The medical device company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.03). The firm had revenue of $34.10 million during the quarter, compared to the consensus estimate of $35.27 million. Cutera had a return on equity of 16.12% and a net margin of 18.54%. Cutera’s revenue was up 16.4% on a year-over-year basis. During the same period last year, the business earned ($0.07) EPS. sell-side analysts expect that Cutera, Inc. will post 0.57 earnings per share for the current year.
A number of institutional investors have recently made changes to their positions in the business. BlackRock Inc. grew its holdings in Cutera by 33.2% in the 4th quarter. BlackRock Inc. now owns 2,015,640 shares of the medical device company’s stock worth $91,409,000 after acquiring an additional 502,933 shares during the last quarter. Renaissance Technologies LLC grew its holdings in Cutera by 3.6% in the 4th quarter. Renaissance Technologies LLC now owns 1,083,600 shares of the medical device company’s stock worth $49,141,000 after acquiring an additional 37,920 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in Cutera by 49.4% in the 4th quarter. Bank of New York Mellon Corp now owns 218,421 shares of the medical device company’s stock worth $9,905,000 after acquiring an additional 72,223 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in Cutera by 10.5% in the 1st quarter. JPMorgan Chase & Co. now owns 188,029 shares of the medical device company’s stock worth $9,449,000 after acquiring an additional 17,855 shares during the last quarter. Finally, Bogle Investment Management L P DE grew its holdings in Cutera by 77.2% in the 4th quarter. Bogle Investment Management L P DE now owns 185,174 shares of the medical device company’s stock worth $8,397,000 after acquiring an additional 80,700 shares during the last quarter. 93.36% of the stock is currently owned by institutional investors and hedge funds.
Cutera Company Profile
Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.